Clinical Research on Foot & Ankle
Open Access

Diabetic foot ulcers; Diabetes mellitus; Neuropathy; Vascular disease; Wound healing; Prevention; Management

Introduction

Diabetic foot ulcers (DFUs) represent a formidable challenge in the realm of diabetic complications, posing significant clinical, economic, and public health burdens globally. As one of the most prevalent complications of diabetes mellitus, DFUs contribute to increased morbidity, mortality, and healthcare costs, while severely impairing the quality of life for affected individuals. Despite advancements in medical care and diabetes management strategies, the incidence of DFUs continues to rise, necessitating a deeper understanding of their pathophysiology, risk factors, and management approaches. The pathogenesis of DFUs is multifactorial, involving a complex interplay of metabolic, neuropathic, vascular, and immunological factors. Chronic hyperglycemia, a hallmark of diabetes, underlies the development of microvascular and macrovascular complications, impairing tissue perfusion and wound healing processes. Concurrent peripheral neuropathy further exacerbates the risk of DFUs by causing loss of protective sensation, altered biomechanics, and increased susceptibility to trauma. Moreover, impaired immune function and compromised host defense mechanisms predispose individuals with diabetes to infection, further complicating the management of DFUs [1].

Identifying the risk factors associated with DFUs is paramount for implementing preventive measures and early intervention strategies. Long-standing diabetes, poor glycemic control, peripheral neuropathy, peripheral arterial disease, foot deformities, trauma, and smoking are among the key risk factors implicated in the development of DFUs. A comprehensive understanding of these risk factors allows for targeted interventions aimed at mitigating the occurrence and progression of DFUs. The clinical presentation and diagnosis of DFUs require a systematic approach, encompassing thorough assessment of the wound characteristics, vascular status, presence of infection, and associated comorbidities. Prompt diagnosis and appropriate management strategies are essential to prevent complications such as infection, gangrene, and lower extremity amputation, which are all too common sequelae of untreated DFUs [2].

Management of DFUs necessitates a multidisciplinary approach, involving collaboration among podiatrists, endocrinologists, vascular surgeons, infectious disease specialists, and wound care experts. Treatment strategies aim to optimize glycemic control, alleviate pressure on the affected area, promote wound healing, prevent infection, and address underlying vascular insufficiency. Interventions may range from wound debridement and offloading devices to surgical interventions and adjunctive therapies such as hyperbaric oxygen therapy and growth factors. In addition to treatment, preventive measures play a crucial role in reducing the burden of DFUs. Patient education on foot care, regular foot examinations, appropriate footwear, and early detection and management of risk factors are essential components of preventive strategies. Comprehensive foot screening programs and multidisciplinary diabetic foot clinics serve as vital platforms for identifying high-risk individuals and implementing targeted interventions to prevent the occurrence of DFUs [3].

In light of the growing prevalence and impact of DFUs, there is an urgent need for continued research aimed at advancing our understanding of their pathophysiology and refining management strategies. Future studies should focus on personalized medicine, innovative therapeutic approaches, and novel wound healing technologies to address the unmet needs in this field. By fostering collaboration among researchers, clinicians, and policymakers, we can strive towards reducing the burden of DFUs and improving the lives of individuals affected by this debilitating complication of diabetes mellitus [4].

Despite the significant strides made in medical science and technology, diabetic foot ulcers (DFUs) remain a pervasive and challenging complication of diabetes mellitus. The burden of DFUs extends beyond the individual level, affecting healthcare systems, economies, and societal well-being. Understanding the intricate interplay of factors contributing to the development and progression of DFUs is essential for devising effective preventive and management strategies. Peripheral neuropathy, a common complication of diabetes, plays a central role in the pathogenesis of DFUs. Sensory neuropathy leads to loss of protective sensation, rendering individuals vulnerable to unnoticed trauma and injury. Motor neuropathy alters biomechanics, causing deformities and abnormal pressure distribution on the feet, further predisposing to ulcer formation. Autonomic neuropathy affects sweat gland function and blood flow regulation, impairing wound healing and increasing susceptibility to infection [5, 6].

Peripheral arterial disease (PAD) is another significant contributor to the pathophysiology of DFUs. Macrovascular complications associated with diabetes, including atherosclerosis and arterial occlusive disease, compromise blood flow to the lower extremities, impairing tissue oxygenation and nutrient delivery. Ischemia exacerbates tissue damage and delays wound healing, significantly impacting the natural history of DFUs. The diabetic foot represents a unique microenvironment conducive to the development of chronic wounds. Prolonged exposure to hyperglycemia induces cellular and molecular changes that impair the normal wound healing process. Chronic inflammation, oxidative stress, impaired angiogenesis, and dysfunctional extracellular matrix remodelling contribute to the perpetuation of DFUs and hinder the effectiveness of conventional treatment modalities [7].

The management of DFUs requires a holistic approach tailored to the individual needs of patients. Wound care principles emphasize debridement of necrotic tissue, maintenance of a moist wound environment, and prevention of infection. Offloading strategies, such as therapeutic footwear and custom orthoses, aim to redistribute pressure away from the ulcer site, promoting healing and preventing recurrence. Surgical interventions, including revascularization procedures and amputation when necessary, play a crucial role in salvaging limbs and improving functional outcomes. Advanced therapeutic modalities, such as growth factors, bioengineered skin substitutes, and negative pressure wound therapy, offer promising avenues for enhancing wound healing in DFUs. Multidisciplinary diabetic foot teams comprising podiatrists, vascular surgeons, endocrinologists, and infectious disease specialists collaborate to deliver comprehensive care and optimize patient outcomes [8, 9].

Prevention remains the cornerstone of DFU management, emphasizing the importance of patient education, regular foot assessments, and early intervention. Lifestyle modifications, including smoking cessation, glycemic control, and regular exercise, are paramount in reducing the risk of DFUs and mitigating their complications. DFUs represent a complex and multifaceted challenge in the management of diabetes mellitus. A comprehensive understanding of the underlying pathophysiology, coupled with a multidisciplinary approach to care, is essential for mitigating the impact of DFUs on individuals and healthcare systems. By integrating preventive measures, innovative treatment modalities, and collaborative care models, we can strive towards reducing the incidence, severity, and sequelae of DFUs, ultimately improving the quality of life for individuals living with diabetes [10].

Conclusion

Despite advances in understanding the pathophysiology and management of DFUs, there is a need for further research to develop novel therapeutic approaches and improve clinical outcomes. Future studies should focus on personalized medicine, targeted therapies, regenerative medicine, and innovative wound healing technologies to address the unmet needs in this field. In conclusion, a comprehensive understanding of the pathogenesis, risk factors, clinical presentation, diagnosis, and management of DFUs is essential for optimizing patient care and reducing the burden of this devastating complication of diabetes mellitus.

Acknowledgement

None

Conflict of Interest

None

1. Stewart S, Dalbeth N, Vandal AC, Rome K (2016) The first metatarsophalangeal joint in gout: a systematic review and meta-analysis. BMC Musculoskelet Disord 17: 69-96.

Indexed at, Google Scholar, Crossref

2. Polachek A, Li S, Chandran V, Gladman D (2017) Clinical enthesitis in a prospective longitudinal psoriatic arthritis cohort: incidence, prevalence, characteristics and outcome: Enthesitis in psoriatic arthritis. Arthritis Care Res 69(11): 1685-1691.

Indexed at, Google Scholar, Crossref

3. Koca TT, Göğebakan H, Koçyiğit BF, Nacitarhan V, Yildir CZ (2019) Foot functions in ankylosing spondylitis. Clin Rheumatol 38(4): 1083-1088.

Indexed at, Google Scholar, Crossref

4. Singer AJ, Tassiopoulos, Kirsner RS (2018) Evaluation and Management of Lower-Extremity Ulcers. N Engl J Med 378(3): 302-303.

Indexed at, Google Scholar, Crossref

5. Armstrong DG, Boulton AJM, Bus SA (2017) Diabetic Foot Ulcers and Their Recurrence. N Engl J Med 376(24): 2367-2375.

Indexed at, Google Scholar, Crossref

6. Kumar S, Pradhan R, Rosenfeld PF (2010) First metatarsophalangeal arthrodesis using a dorsal plate and a compression screw. Foot Ankle Int 31(9): 797-801.

Indexed at, Google Scholar, Crossref

7. Morgan S, Ng A, Clough T (2012) The long-term outcome of silastic implant arthroplasty of the first metatarsophalangeal joint: a retrospective analysis of one hundred and eight feet. Int Orthop 36(9): 1865-1869.

Indexed at, Google Scholar, Crossref

8. Shereff MJ, Jahss MH (1980) Complications of silastic implants arthroplasty in the hallux. Foot Ankle 1(2): 95-101.

Indexed at, Google Scholar, Crossref

9. Cracchiolo A, Weltmer JB, Lian G, Dalseth T, Dorey F (1992) Arthroplasty of the first metatarsophalangeal joint with a double-stem silicone implant: results in patients who have degenerative joint disease failure of previous operations, or rheumatoid arthritis. J Bone Joint Surg 74: 552-563.

Indexed at, Google Scholar

10. McNearney T, Haque A, Wen J, Lisse J (1996) Inguinal lymph node foreign body granulomas after placement of a silicone rubber (Silflex) implant of the first metatarsophalangeal joint. J Rheumatol 23: 1449-1452.

Indexed at, Google Scholar